Research shows semaglutide — commonly sold as Ozempic or Wegovy — can improve kidney function and survival rates for people ...

When the results of the SELECT trial landed in the New England Journal of Medicine in November 2023, they confirmed what ...

Researchers report that the weight loss drugs semaglutide and tirzepatide can reduce the risk of hospitalization and death by 40% in people with a common type of heart failure. Experts say this large ...

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart ...

Optimized treatment can reduce the mortality risk for chronic heart failure (HF) by as much as 60%. The role of appropriate drug combinations and rapid diagnosis was discussed at the 91st Annual ...

Adding to a growing body of research about the related health benefits of diabetes weight-loss drugs, an August 31 study in the Journal of the American Medical Association found that semaglutide and ...

New drugs and a growing awareness of the common condition offer hope for patients. By Nina Agrawal Ann Ramirez first noticed something was wrong when, at age 48, she started waking up in the middle of ...

ROCKVILLE, Md., Aug. 14 -- The makers of rosiglitazone (Avandia) and pioglitazone (Actos), have agreed to add a black box warning to the type 2 diabetes drugs' labels about an increased risk of heart ...

Commonly used medications and nutritional supplements may cause or worsen heart failure, according to the first scientific statement from the American Heart Association to provide guidance on avoiding ...

Emerging details follow a May 12 report affecting more than 17,000 bottles of a commonly prescribed blood pressure drug.

A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for ...